FMC closes $403M Tessenderlo stake as debt relief comes with board influence

FMC is trying to stabilize a pressured crop-protection business while cutting debt and funding its next product cycle: second-quarter revenue fell 17% year over year amid weaker partner orders, lower legacy-product demand and pricing pressure, while management has been pursuing asset sales and strategic alternatives. This filing completes the previously announced financing, rather than changing the strategic direction. Tessenderlo has now bought 30,319,166 shares for $13.30 each, paying approximately $403 million and ending with about 20% of FMC. 〔0〕 The agreement was announced on June 30, so the transaction itself was already known; the new information is that closing conditions and regulatory approvals are complete. The capital helps FMC’s repair effort, but it is not free money. The investment adds meaningful liquidity for debt reduction—the stated purpose when the deal was announced—but creates substantial dilution and gives Tessenderlo an unusually durable position: one independent board nominee, a board observer, voting support for management on most matters, preemptive rights and the ability to maintain a 20% stake. Governance influence is the main buried consequence. Tessenderlo has nominated its CEO, Luc Tack, for the board, while a three-year lock-up and standstill reduce near-term takeover or activist risk. 〔1〕 The arrangement gives FMC a committed strategic shareholder while limiting the company’s flexibility around future ownership changes and equity issuance. Bottom line: This is a known transaction now made final: helpful for FMC’s deleveraging plan, but at the cost of dilution and meaningful influence for a 20% shareholder. DTSTART